Table 1.
Preparative technique | Merits | Demerits | Application | Microsphere-drug combination | Ref. |
---|---|---|---|---|---|
Emulsion-solidication | Large-scale production, simple operation | Wide particle size | Oncotherapy Neuralrepair |
|
[88,188,189] |
Microfluidics | Unique analytical performance, smaller volume, good monodispersity | Low production efficiency | Oncotherapy | 5-Fu loaded CS microspheres | [30,35] |
Mold method | Low cost, simple operation | Complex synthesis process | Protein separation | Monodisperse porous silica microspheres | [58,62,63] |
Microfluidic electrospray | Uniform size and good monodispersity | Low production efficiency | Skin wounds | Novel drug-loaded methacryloyl chondroitin sulfate (CSMA) microspheres | [67, 196] |
Spray drying | Simple and stable | Limited range of polymers | Gastropathy | Chitosan-based microspheres | [75] |
Self-assembly method | Simple production technology, mild reaction conditions, and suitability for hydrophilic and hydrophobic drugs | Size and monodispersity need to be improved | Oncotherapy | Paclitaxel-loaded silk fibroin nanospheres | [78] |
Phase separation method | For water-soluble drugs, easy to prepare in batches | Difficult to remove organic solvents | Arthritis | Loaded sPL sustained-release microspheres | [206] |
Membrane emulsification method | Particle size uniformity, mild conditions, simple equipment and energy saving | Small dispersion flux, low production efficiency | The organic-inorganic hybrid composites | Biopolymer-inorganic hybrid microspheres | [87] |